Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel

DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Valeant Pharmaceutical In... Biopharmaceuticals, Generics, FDA, Product LaunchPerrigo, BenzaClin, Valeant Pharmaceutical
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news